Brett Sheppard

Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.

Endoscopic ultrasound may be unnecessary in the preoperative evaluation of intraductal papillary mucinous neoplasm.

The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.

Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.

N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.

Coagulopathy after a liver resection: is it over diagnosed and over treated?

Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer.

Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.

Familial jejuno-ileal diverticulitis: A case report and review of the literature.

Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.

ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.

Evolution in the Treatment of Esophageal Disease at a Single Academic Institution: 2004-2013.

MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance.

Effect of a hospital-associated urinary tract infection reduction policy on general surgery patients.

Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.

Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.

Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.

Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting.

Pheochromocytoma: 20 years of improving surgical care.

Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study.

International multicentre review of perioperative management and outcome for catecholamine-producing tumours.

Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study.

Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer.

Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.

Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors.

Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study.

Intraoperative Bile Culture in Pancreaticoduodenectomy: Teaching Old Dogma New Tricks.

Psychosocial distress is dynamic across the spectrum of cancer care and requires longitudinal screening for patient-centered care.

Disparities in pancreatic cancer care and research in Native Americans: Righting a history of wrongs.

Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications.

Risk factors for postoperative pancreatic fistula in the Era of pasireotide.

The power of suction: Theory and practice in closed suction vs gravity drains and postoperative pancreatic fistulas.

Similar Outcomes in Minimally Invasive versus Open Management of Primary Pancreatic Neuroendocrine Tumors: A Regional, Multi-Institutional Collaborative Analysis.

Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis.

Validation of automated body composition analysis using diagnostic computed tomography imaging in patients with pancreatic cancer.

Complications in Distal Pancreatectomy versus Radical Antegrade Modular Pancreatosplenectomy: A Disease Risk Score Analysis Utilizing National Surgical Quality Improvement Project Data.

Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer.

Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors.

Socioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers.

High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer.

Referral and treatment patterns in pancreatic acinar cell carcinoma: A regional population-level analysis.

Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.

Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment.